688639 Stock Overview
Engages in the development, production, and sale of amino acids and other organic acids in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
Anhui Huaheng Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥36.00 |
| 52 Week High | CN¥90.00 |
| 52 Week Low | CN¥26.52 |
| Beta | 0.014 |
| 11 Month Change | 8.04% |
| 3 Month Change | -9.27% |
| 1 Year Change | -54.40% |
| 33 Year Change | -11.48% |
| 5 Year Change | n/a |
| Change since IPO | 114.73% |
Recent News & Updates
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21
Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Recent updates
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Shareholder Returns
| 688639 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 7.1% | 6.8% | 7.1% |
| 1Y | -54.4% | -2.3% | 9.1% |
Return vs Industry: 688639 underperformed the CN Chemicals industry which returned -2.3% over the past year.
Return vs Market: 688639 underperformed the CN Market which returned 9.1% over the past year.
Price Volatility
| 688639 volatility | |
|---|---|
| 688639 Average Weekly Movement | 12.4% |
| Chemicals Industry Average Movement | 7.3% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688639's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688639's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,691 | Henghua Guo | www.huahengbio.com |
Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers inositol, D-calcium pantothenate, L-valine, DL- alanine, L-citrulline, DL-malic acid, L-alanine, D-panthenol, L-citrulline DL-malate, L-malic acid, beta-alanine, a- arbutin, L-arginine, ß-arbutin, L-glycine, L-proline, amino acid concentrate, compound amino acid power, microbial inoculum, compound microbial fertilizer, and water soluble fertilizer products. Its products are used in daily chemical, medicine, health and personal care products, food additives, feeds, animal nutrition, plant nutrition, and functional nutrition.
Anhui Huaheng Biotechnology Co., Ltd. Fundamentals Summary
| 688639 fundamental statistics | |
|---|---|
| Market cap | CN¥8.20b |
| Earnings (TTM) | CN¥299.01m |
| Revenue (TTM) | CN¥2.11b |
27.4x
P/E Ratio3.9x
P/S RatioIs 688639 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688639 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.11b |
| Cost of Revenue | CN¥1.46b |
| Gross Profit | CN¥652.02m |
| Other Expenses | CN¥353.01m |
| Earnings | CN¥299.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.31 |
| Gross Margin | 30.86% |
| Net Profit Margin | 14.15% |
| Debt/Equity Ratio | 110.1% |
How did 688639 perform over the long term?
See historical performance and comparison